Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2020 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (180)	10/30/2020 8:10:07 PM
From: DewDiligence_on_SI	Read Replies (1) \| Respond to of 259

Please don't hurt yourself, Marty, but let's be honest about our motivations as biotech investors: twitter.com

To: BulbaMan who wrote (180)	11/6/2020 10:57:37 PM
From: BulbaMan	Read Replies (1) \| Respond to of 259

11/6/2020 Contest update (Contest and Index YTDs are calculated from 1/3/2020 close.) No “Blue Wave” but rather a “Blue Ripple.” However, I’ll definitely take it over the 2016 rip current. As for the impact of the election results on biotechs, the conventional wisdom is that a likely divided government reduces the threat of drug price controls. So biotech bulls should be happy. Meanwhile, at Friday’s close, the Contest median was up 14.70% YTD (vs. up 9.06% YTD a week ago), the Nasdaq Biotech Index (NBI) was up 17.24% YTD (vs. up 10.30% YTD a week ago), the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 28.28% YTD (vs. up 20.43% YTD a week ago), while the Nasdaq Composite Index (NCI) was up 31.86% YTD (vs. up 20.96% YTD a week ago). (We’ll see Monday whether this afternoon’s ADCOM thumbs down on BIIB’s aducanumab has a negative effect on the entire biotech sector.) JBOG’s portfolio had a good week, holding on to a big Contest lead with a 220.94% YTD gain. FILO’s portfolio, up 141.80% YTD and MASTER’s portfolio, up 92.27% YTD, continued in second and third place. At Friday's close, 26 of the 42 Contest portfolios were in the green, with 19 beating the NBI and 13 beating the SPSIBI. The 197 Contest stock picks have an average YTD gain of 23.01% with the median still in the red with a YTD loss of -4.20%. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.) Portfolio adjustments: None. (All corrections, especially adjustments for splits & mergers, greatly appreciated.) Enjoy a safe and relaxing pot-election (sic) week biotechies. Don’t forget to wear your mask and social distance. Peace & good health, Bulba 11/6/20 Rank Name Profit/Loss 1 JBOG 220,941 2 FILO 141,795 3 MASTER 92,268 4 OLIVIER 78,660 5 BIOSCI 58,063 6 DOUGH 52,675 7 IPOL 48,966 8 BMAZ 42,965 9 BLADE 37,041 10 AJM 33,932 Week's Top 5 Gainers Symbol 10/30 11/6 Wk.%chg. OCUL 9.500 12.840 35.16% BIIB 252.070 328.900 30.48% SAVA 8.210 10.700 30.33% SLN.L 345.000 441.000 27.83% DNLI 42.780 54.240 26.79% Week's Worst 5 Losers Symbol 10/30 11/6 Wk.%chg. ASMB 14.740 4.870 -66.96% BMY-RI 3.260 1.260 -61.35% ARYC 0.002 0.001 -30.00% GBT 52.880 38.210 -27.74% AMRS 2.500 1.890 -24.40%